Brief: Shanghai Junshi Biosciences Says Received Acceptance Notice Issued By NMPA For New Drug Application For Toripalimab
12/08/2024 16:34
Aug 12 (Reuters) - Shanghai Junshi Biosciences Co Ltd
688180.SS :
* RECEIVED ACCEPTANCE NOTICE ISSUED BY NMPA FOR NEW DRUG
APPLICATION FOR TORIPALIMAB
Further company coverage: 688180.SS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shanghai Junshi Biosciences
See all newsBrief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Q3 Net Loss At 170.9 Million Yuan
Brief: Shanghai Junshi Biosciences Receives Supplemental Drug Approval From NMPA
Brief: Shanghai Junshi Biosciences's Shareholder Plans To Cut Stake
Brief: Shanghai Junshi Biosciences Gets NMPA Acceptance Notice Of Supplemental Application For Toripalimab